EXTRACTS OF THE HAEMOPOIETIC SYSTEM

Extracts of the hemopoietic chalones, erythrocytic, lymphocytic and granulocytic chalones are produced by the semi-continuous processing of whole blood. By means of a continuous lysis unit the red blood cells are preferentially and substantially completely lysed while leaving unaffected the leucocyt...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	WILLIAM ARTHUR JONES, HENRY FRANCIS FROST, TAPIO RYTOMAA, NORMAN JAMES HARPER, TSE LIAN SIN TSE HING YUEN
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	WILLIAM ARTHUR JONES HENRY FRANCIS FROST TAPIO RYTOMAA NORMAN JAMES HARPER TSE LIAN SIN TSE HING YUEN
description	Extracts of the hemopoietic chalones, erythrocytic, lymphocytic and granulocytic chalones are produced by the semi-continuous processing of whole blood. By means of a continuous lysis unit the red blood cells are preferentially and substantially completely lysed while leaving unaffected the leucocytes which are then separated together with the red cell debris by means of a centrifuge in which the leucocytes attach to the rotor. The intact leucocytes are extracted and the extract subjected to ultrafiltration to provide extracts of the hemopoietic chalones, which may be further isolated and purified. Patients suffering from myeloid leukaemia have achieved temporary remissions with minimal serious or dangerous side effects when the patients received repeated doses of granulocytic chalone over an extended treatment period.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU515950BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU515950BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU515950BB23</originalsourceid><addsrcrecordid>eNrjZFB2jQgJcnQOCVbwd1MI8XBV8HB09fUP8Pd0DfF0VgiODA5x9eVhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGOoaaGppamBk5ORsZEKAEAIvwijg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>EXTRACTS OF THE HAEMOPOIETIC SYSTEM</title><source>esp@cenet</source><creator>WILLIAM ARTHUR JONES ; HENRY FRANCIS FROST ; TAPIO RYTOMAA ; NORMAN JAMES HARPER ; TSE LIAN SIN TSE HING YUEN</creator><creatorcontrib>WILLIAM ARTHUR JONES ; HENRY FRANCIS FROST ; TAPIO RYTOMAA ; NORMAN JAMES HARPER ; TSE LIAN SIN TSE HING YUEN</creatorcontrib><description>Extracts of the hemopoietic chalones, erythrocytic, lymphocytic and granulocytic chalones are produced by the semi-continuous processing of whole blood. By means of a continuous lysis unit the red blood cells are preferentially and substantially completely lysed while leaving unaffected the leucocytes which are then separated together with the red cell debris by means of a centrifuge in which the leucocytes attach to the rotor. The intact leucocytes are extracted and the extract subjected to ultrafiltration to provide extracts of the hemopoietic chalones, which may be further isolated and purified. Patients suffering from myeloid leukaemia have achieved temporary remissions with minimal serious or dangerous side effects when the patients received repeated doses of granulocytic chalone over an extended treatment period.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1981</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19810514&DB=EPODOC&CC=AU&NR=515950B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19810514&DB=EPODOC&CC=AU&NR=515950B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WILLIAM ARTHUR JONES</creatorcontrib><creatorcontrib>HENRY FRANCIS FROST</creatorcontrib><creatorcontrib>TAPIO RYTOMAA</creatorcontrib><creatorcontrib>NORMAN JAMES HARPER</creatorcontrib><creatorcontrib>TSE LIAN SIN TSE HING YUEN</creatorcontrib><title>EXTRACTS OF THE HAEMOPOIETIC SYSTEM</title><description>Extracts of the hemopoietic chalones, erythrocytic, lymphocytic and granulocytic chalones are produced by the semi-continuous processing of whole blood. By means of a continuous lysis unit the red blood cells are preferentially and substantially completely lysed while leaving unaffected the leucocytes which are then separated together with the red cell debris by means of a centrifuge in which the leucocytes attach to the rotor. The intact leucocytes are extracted and the extract subjected to ultrafiltration to provide extracts of the hemopoietic chalones, which may be further isolated and purified. Patients suffering from myeloid leukaemia have achieved temporary remissions with minimal serious or dangerous side effects when the patients received repeated doses of granulocytic chalone over an extended treatment period.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1981</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB2jQgJcnQOCVbwd1MI8XBV8HB09fUP8Pd0DfF0VgiODA5x9eVhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGOoaaGppamBk5ORsZEKAEAIvwijg</recordid><startdate>19810514</startdate><enddate>19810514</enddate><creator>WILLIAM ARTHUR JONES</creator><creator>HENRY FRANCIS FROST</creator><creator>TAPIO RYTOMAA</creator><creator>NORMAN JAMES HARPER</creator><creator>TSE LIAN SIN TSE HING YUEN</creator><scope>EVB</scope></search><sort><creationdate>19810514</creationdate><title>EXTRACTS OF THE HAEMOPOIETIC SYSTEM</title><author>WILLIAM ARTHUR JONES ; HENRY FRANCIS FROST ; TAPIO RYTOMAA ; NORMAN JAMES HARPER ; TSE LIAN SIN TSE HING YUEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU515950BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1981</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WILLIAM ARTHUR JONES</creatorcontrib><creatorcontrib>HENRY FRANCIS FROST</creatorcontrib><creatorcontrib>TAPIO RYTOMAA</creatorcontrib><creatorcontrib>NORMAN JAMES HARPER</creatorcontrib><creatorcontrib>TSE LIAN SIN TSE HING YUEN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WILLIAM ARTHUR JONES</au><au>HENRY FRANCIS FROST</au><au>TAPIO RYTOMAA</au><au>NORMAN JAMES HARPER</au><au>TSE LIAN SIN TSE HING YUEN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>EXTRACTS OF THE HAEMOPOIETIC SYSTEM</title><date>1981-05-14</date><risdate>1981</risdate><abstract>Extracts of the hemopoietic chalones, erythrocytic, lymphocytic and granulocytic chalones are produced by the semi-continuous processing of whole blood. By means of a continuous lysis unit the red blood cells are preferentially and substantially completely lysed while leaving unaffected the leucocytes which are then separated together with the red cell debris by means of a centrifuge in which the leucocytes attach to the rotor. The intact leucocytes are extracted and the extract subjected to ultrafiltration to provide extracts of the hemopoietic chalones, which may be further isolated and purified. Patients suffering from myeloid leukaemia have achieved temporary remissions with minimal serious or dangerous side effects when the patients received repeated doses of granulocytic chalone over an extended treatment period.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_AU515950BB2
source	esp@cenet
subjects	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	EXTRACTS OF THE HAEMOPOIETIC SYSTEM
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T22%3A37%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WILLIAM%20ARTHUR%20JONES&rft.date=1981-05-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU515950BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true